Danielle Novetsky Friedman, MD, MS, is a pediatrician specializing in pediatric cancer survivorship and long-term follow-up care. She serves as Associate Attending Pediatrician and Associate Professor in the Department of Pediatrics at MSK Kids, Memorial Sloan Kettering Cancer Center, where she is also Program Director of the Pediatric Survivorship Fellowship and an attending pediatrician in the Pediatric Long-Term Follow-Up Program. In her clinical practice, Dr. Friedman focuses on survivorship care for children, adolescents, and young adults, surveillance for treatment-related late effects, and health counseling that supports transition to adult-focused care. Dr. Friedman’s research centers on the late effects of cancer therapy, cardiometabolic and endocrine outcomes after treatment exposure, and optimization of risk-based screening and survivorship guidelines. Her work reflects a strong commitment to improving long-term health outcomes and advancing evidence-based survivorship care. A recognized leader in the field, Dr. Friedman is Co-Chair of the Children’s Oncology Group Long-Term Follow-Up Guidelines Task Force on Second Malignancy and Cancer Screening and has received support and recognition through the American Cancer Society Clinician Scientist Development Grant, the CTSC KL2 Career Development Scholar Award, the Chanel Endowment to Fund Survivorship Research Award, and Castle Connolly Top Doctor honors. She earned her medical degree from Albert Einstein College of Medicine, completed her pediatrics residency at NewYork-Presbyterian/Weill Cornell Medical Center, served as Pediatric Chief Resident at Memorial Sloan Kettering Cancer Center, and pursued advanced clinical and research training in pediatric cancer survivorship and long-term follow-up at Memorial Sloan Kettering.
Associate Professor
Medical School
2003 – 2007
Residency
2007 – 2010
Fellowship
2011 – 2012